Antleron
Peter Mercelis is an experienced entrepreneur and executive in the medical technology field, currently serving as Co-Founder and CEO of Replasia BV, a company focused on innovative treatments for hip dysplasia. Mercelis holds advisory and leadership roles in multiple organizations, including Onicor, Amnovis, and AdditiveLab, contributing to advancements in drug delivery, additive manufacturing, and medical devices. As a board member for Antleron and former non-executive chairman at Bond High Performance 3D Technology, Mercelis plays a significant role in the development of next-generation therapies and 3D printing technologies. A graduate of KU Leuven with a PhD in Mechanical Engineering, Mercelis has a strong foundation in healthcare innovations, previously holding a director position at 3D Systems Corporation.
This person is not in the org chart
This person is not in any teams
Antleron
We are Antleron, a nimble team that will revolutionise medicine by leading the development of next generation advanced therapies and medical devices. By merging the potential of cells, biomaterials, biologics, 3D printing and bioreactors we will accelerate the engineering of medicinal products, devices and processes that will change health care and result in a better life for all. The Antleron business philosophy is to create sustainable ventures through risk & reward sharing partnerships based on the adoption of our game changing team know-how and technology platforms.